Abstract
The activities of Hageman factor, high molecular weight kininogen (HMWK), and prekallikrein were studied in patients who had chronic active hepatitis and cirrhosis. Serum HMWK and prekallikrein activities were decreased in chronic active hepatitis and cirrhosis, but Hageman factor activity was low in cirrhosis only. The reduction of prekallikrein, HMWK, and Hageman factor was dependent on the degree of liver failure. Similar prekallikrein values were found in serum samples, activated or not, with an excess of Hageman factor and HMWK, which suggests that the decrease of prekallikrein in liver disease is not influenced by the simultaneous decrease of Hageman factor and HMWK.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Colman R. W., Mattler L., Sherry S. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein. J Clin Invest. 1969 Jan;48(1):23–32. doi: 10.1172/JCI105971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cordova C., Musca A., Violi F., Alessandri C., Ferro D., Piromalli A., Balsano F. Prekallikrein behaviour in chronic active hepatitis and in cirrhotic patients. Haemostasis. 1984;14(2):218–222. doi: 10.1159/000215059. [DOI] [PubMed] [Google Scholar]
- Cordova C., Violi F., Alessandri C., Musca A., Balsano F. Low doses of calcium-heparin in liver cirrhosis. Thromb Haemost. 1985 Aug 30;54(2):551–551. [PubMed] [Google Scholar]
- Franco D., Durandy Y., Deporte A., Bismuth H. Upper gastrointestinal haemorrhage in hepatic cirrhosis: causes and relation to hepatic failure and stress. Lancet. 1977 Jan 29;1(8005):218–220. doi: 10.1016/s0140-6736(77)91015-7. [DOI] [PubMed] [Google Scholar]
- Kluft C. Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein. J Lab Clin Med. 1978 Jan;91(1):83–95. [PubMed] [Google Scholar]
- Liu C. Y., Scott C. F., Bagdasarian A., Pierce J. V., Kaplan A. P., Colman R. W. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen. J Clin Invest. 1977 Jul;60(1):7–17. doi: 10.1172/JCI108770. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robinson J. A., Klondnycky M. L., Loeb H. S., Racic M. R., Gunnar R. M. Endotoxin, prekallikrein, complement and systemic vascular resistance. Sequential measurements in man. Am J Med. 1975 Jul;59(1):61–67. doi: 10.1016/0002-9343(75)90322-8. [DOI] [PubMed] [Google Scholar]
- Saito H., Goldsmith G., Waldmann R. Fitzgerald factor (high molecular weight kininogen) clotting activity in human plasma in health and disease in various animal plasmas. Blood. 1976 Dec;48(6):941–947. [PubMed] [Google Scholar]
- Stormorken H., Baklund A., Gallimore M., Ritland S. Chromogenic substrate assay of plasma prekallikrein. With a note on its site of biosynthesis. Haemostasis. 1978;7(2-3):69–75. doi: 10.1159/000214237. [DOI] [PubMed] [Google Scholar]
- Violi F., Alessandri C., Saliola M., Caputo V., Bonavita M. S., Balsano F. Correlation between hepatic blood flow and coagulation indices in chronic active hepatitis and liver cirrhosis patients. Haemostasis. 1985;15(3):210–214. doi: 10.1159/000215146. [DOI] [PubMed] [Google Scholar]